Filing Details
- Accession Number:
- 0001225208-13-022425
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-29 19:11:02
- Reporting Period:
- 2013-10-25
- Filing Date:
- 2013-10-29
- Accepted Time:
- 2013-10-29 19:11:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1453458 | M Sharon Alterio | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Group Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-10-25 | 2,452 | $134.86 | 44,580 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-10-28 | 11,550 | $83.47 | 56,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-10-28 | 11,550 | $134.92 | 44,580 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2013-10-28 | 11,550 | $0.00 | 11,550 | $83.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-07-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 137 | Indirect | 401(k) Plan |
Footnotes
- Represents the weighted average sales price for price increments ranging from $134.81 to $134.91. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $134.85 to $135.06. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Options fully vested in accordance with schedule upon achievement of certain performance criteria.
Billionaire Hedge Funds
